Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / OVID - Revisiting Ovid Therapeutics

OVID - Revisiting Ovid Therapeutics

Ovid Therapeutics Inc.
  • We revisit 'Tier 4' biotech concern Ovid Therapeutics for the first time since last summer.
  • The shares cratered in December after failed trial results from its primary drug candidate.
  • However, the company is still well funded and has some other 'shots on goal' in its pipeline.
  • We revisit and update the investment case on Ovid in the paragraphs below.

For further details see:

Revisiting Ovid Therapeutics
Stock Information
Company Name: Ovid Therapeutics Inc.
Stock Symbol: OVID
Market: NASDAQ
Website: ovidrx.com
Menu
OVID OVID Quote OVID Short OVID News OVID Articles OVID Message Board
Get OVID Alerts

News, Short Squeeze, Breakout and More Instantly...